📰 Alembic News
Alembic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alembic. Real-time updates on events, politics, business and more.
May 4, 2024
After India lost its dominance in making penicillin, a drought of three decades is coming to an end. The drug – which forms the base for a raft of extremely potent antibiotics – is part of the governments aggressive push for self-sufficiency in critical areas. Will the plan to claw back to the glorious past work?
March 26, 2024
With the chipmaker dominating the AI processor market, startups in the sector are raising more money and devoting increasing portions of it to hardware — leaving less for everything else.
March 26, 2024
With the chipmaker dominating the AI processor market, startups in the sector are raising more money and devoting increasing portions of it to hardware — leaving less for everything else.
February 15, 2024
Sales software maker Alembic to double staff in San Francisco after raising $14M. The startup has designed an AI system that analyzes data to predict the return on investment of marketing messages.
February 6, 2024
The Vadodra-based pharma manufacturer does not foresee additional capital expenditure for these initiatives but is shifting its strategic focus on new generation drugs over legacy products
December 4, 2023
SPONSORED | Crafted in the Cape winelands, this golden elixir is nothing less than exceptional: it presents a depth and complexity of flavour like no other
August 15, 2023
Alembic Pharmaceuticals plans to launch 20 new products in the US market in FY24, including oncology and non-oncology injectables, derma, and ophthalmic products. The launches will be facilitated by the newly USFDA-compliant facilities. The company also plans to take advantage of drug shortages in the US.
August 14, 2023
A slow offtake in the acute season resulted in weaker sales within the segment, dragging overall sales growth in the domestic pharma market in July.
August 4, 2023
The Vadodara-based company said consolidated profit rose to 1.21 billion rupees ($14.6 million) for the quarter ended June 30 from a loss of 658.8 million rupees a year earlier.
August 3, 2023
Stocks in focus today: Indian stock market could remain subdued given the gloomy global environment. Stock-specific action is likely to continue in the market with the ongoing result season. Bharti Airtel, Sun Pharma, Titan Company, Adani Wilmar, IndiGo, Zomato among stocks in news on Thursday, August 3, 2023.